Researchers find artificial pancreas useful for type 2 diabetes patients
Cambridge scientists have successfully trialled an artificial pancreas for use by patients living with type 2 diabetes. The device - powered by an algorithm developed at the University of Cambridge - doubled the amount of time patients were in the target range for glucose compared to standard treatment and halved the time spent experiencing high glucose levels.
Around 415 million people worldwide are estimated to be living with type 2 diabetes, which costs around $760 billion in annual global health expenditure. According to Diabetes UK, in the UK alone, more than 4.9 million people have diabetes, of whom 90% have type 2 diabetes, and this is estimated to cost the NHS £10bn per year.
Reference:
Daly, A. B., Boughton, (2023), Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial. Nature Medicine. DOI: 10.1038/s41591-022-02144-z
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd